OEC year-end numbers dip
Mobile C-arm manufacturer OEC Medical Systems last week postedlower income and revenues for its 1994 fiscal year (end-December).The Salt Lake City company said market pressures and delays inshipping its new Series 9600 mobile C-arm may have affected
Mobile C-arm manufacturer OEC Medical Systems last week postedlower income and revenues for its 1994 fiscal year (end-December).The Salt Lake City company said market pressures and delays inshipping its new Series 9600 mobile C-arm may have affected itsfinancial numbers.
Despite the dip, OEC was profitable last year by a wide margin.Revenues for the year were $98.2 million, a drop of 1.8% overthe $100 million in sales recorded in 1993. Net income was $8.7million, 11% lower than the $9.8 million registered in the previousyear.
OEC president and CEO David Rose said the company experiencedshipping delays in the second quarter for Series 9600. In addition,the company's year-end backlog has decreased by about one-thirdover last year due to lengthening sales cycles and market pressures.Still, OEC is experiencing increased acceptance of Series 9600and the company has successfully reduced operating expenses, accordingto Rose.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
